Virtual Tumor Board: Neoadjuvant for Stage III NSCLC
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion on the role of neoadjuvant therapy for stage III NSCLC using a virtual tumor board format. This area has become incre...
21 Nov 202347min
LCC in Dutch: Lung Cancer Care in The Netherlands
This episode of Lung Cancer Considered covers the current treatment and research landscape in The Netherlands. The episode is recorded in Dutch and is hosted by Dr. Lizza Hendriks from the Maastricht...
17 Nov 202353min
AEGEAN and Beyond: Perioperative Immunotherapy for NSCLC
Lung Cancer Considered host Dr. Narjust Florez leads an informed discussion on the AEGEAN Trial, which explored neoadjuvant durvalumab plus chemotherapy followed by adjuvant durvalumab in patients wit...
14 Nov 202340min
Updated IASLC - Hindi
Title: Lung Cancer Care in India: Approaching a Lung Cancer Diagnosis (Hindi language podcast) The podcast is recorded in Hindi and covers a range of crucial lung cancer topics, including the emergen...
10 Nov 202350min
FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC
In this podcast, host Dr. Stephen Liu moderates a discussion a recent FDA approval and a specific molecular subtype of NSCLC. On October 11, 2023, the US FDA granted approval to encorafenib and binime...
6 Nov 202342min
ESMO 2023 Highlights: Early Stage NSCLC, SCLC, Thymic Carcinoma
Part 2 of our podcast coverage on ESMO 2023 includes an in-depth interview with Dr. Jarushka Naidoo on early-stage NSCLC, including updates from CheckMate816, Keynote 671 overall survival results, and...
1 Nov 202345min
ESMO 2023 Highlights: Metastatic NSCLC
In the first part of two podcasts covering recent data presented at the European Society of Medical Oncology Congress 2023, host Dr. Stephen Liu summarizes the most compelling research on metastatic n...
30 Okt 202345min
Lung Cancer Care and Research in Japanese
Today’s episode of Lung Cancer Considered is recorded entirely in Japanese and focuses on EGFR mutated lung cancer.
27 Okt 202354min
